BofA Securities Reaffirms Buy Rating for Merck & Co with Target Price of $166
BofA Securities analyst Jason Gerberry has reaffirmed his 'Buy' rating for Merck & Co (MRK.US) and kept its target price at $166.
Gerberry's success rate stands at 62.9% with a total average return of 22.0% over the past year, according to TipRanks data.
The analyst's performance is reflected in his 5-star rating on TipRanks, indicating exceptional accuracy and returns based on his recommendations.